MedTrace Logo

6-Year Follow-up of a Prevention Program for Bereaved Families

NCT01008189 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 244

Last updated 2009-11-04

No results posted yet for this study

Summary

Six-years following participation in the Family Bereavement Program (FBP) participants in the program as compared to a self-study control group will have lower levels of mental health problems, lower one-year prevalence of mental disorder that meets diagnostic criteria, lower use of substances, higher levels of competence at achieving developmentally appropriate tasks in academic achievement and social competence, and better self-esteem. The effects of the FBP will be moderated by baseline levels of mental health problems and gender. Bereaved caregivers who participated in the program will also show lower levels of mental health problems as compared with controls.

Program effects will be mediated by theoretical mediators targeted by the program.

Conditions

  • Mental Disorders Diagnosed in Childhood

Interventions

BEHAVIORAL

Self- study comparison group

Caregivers, children and adolescents each received three books about coping with grief following the death of a loved one plus a syllabus to guide reading

BEHAVIORAL

Family Bereavement Program

12 session groups for caregivers and bereaved children and adolescents plus two individual sessions

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Arizona State University

    lead OTHER

Principal Investigators

  • Irwin N Sandler, Ph.D. · Arizona State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1996-01-31
Primary Completion
2005-07-31
Completion
2009-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01008189 on ClinicalTrials.gov